Weight Loss & GLP-1 Peptides
Do GLP-1 Medications Need to Be Stopped Before Surgery?
02
Sep
Sep
- WE SHIP WITHIN 24 HOURS USPS PRIORITY MAIL 3-5 DAYS
- WE SHIP WITHIN 24 HOURS USPS PRIORITY MAIL 3-5 DAYS
Questions about GLP-1 medicines before surgery remain highly searched because professional guidance has evolved. The central concern is delayed gastric emptying: food may remain in the stomach longer, increasing the possibility of regurgitation or aspiration during anesthesia or deep sedation.
Multi-society guidance does not support a single rule for every patient. Many people may continue their medicine, while patients with significant gastrointestinal symptoms, recent dose escalation or other risk factors may need a modified plan.
The surgical team may consider symptoms, the procedure, anesthesia type, other conditions and the clinical consequences of interrupting treatment. Risk-reduction strategies can include dietary modification, assessment of stomach contents in selected settings, or postponement when risk is unusually high.
Patients should tell the surgeon, anesthesiologist and prescribing clinician about every medication they use, including GLP-1 and dual GIP/GLP-1 medicines. The decision should be made by the care team—not from a generalized social-media instruction.
Current multi-society guidance favors individualized assessment rather than an automatic rule for everyone.
Persistent nausea, vomiting, bloating or other symptoms suggesting delayed gastric emptying should be reported promptly.
No. Follow the instructions from the surgical and anesthesia teams.
Authoritative sources: ASA patient guidance: Authoritative source ; multi-society guidance: Authoritative source
